thymidine 5'-triphosphate has been researched along with Intestinal Neoplasms in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Lin, DM; Macfarlane, AJ; McEntee, MF; Perry, CA; Stover, PJ | 1 |
Erlichman, C; Kaufmann, SH; Mullany, S; Svingen, PA | 1 |
2 other study(ies) available for thymidine 5'-triphosphate and Intestinal Neoplasms
Article | Year |
---|---|
Shmt1 heterozygosity impairs folate-dependent thymidylate synthesis capacity and modifies risk of Apc(min)-mediated intestinal cancer risk.
Topics: Adenomatous Polyposis Coli Protein; Animals; Blotting, Western; Cells, Cultured; Colon; Diet; Enterocytes; Epithelial Cells; Female; Folic Acid; Gene Expression Profiling; Glycine Hydroxymethyltransferase; Heterozygote; Immunohistochemistry; Intestinal Neoplasms; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Mutant Strains; Oligonucleotide Array Sequence Analysis; Purines; Reverse Transcriptase Polymerase Chain Reaction; Risk Factors; Thymine Nucleotides | 2011 |
Effect of adding the topoisomerase I poison 7-ethyl-10-hydroxycamptothecin (SN-38) to 5-fluorouracil and folinic acid in HCT-8 cells: elevated dTTP pools and enhanced cytotoxicity.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Cell Cycle; Cell Survival; Deoxyuracil Nucleotides; DNA Topoisomerases, Type I; Dose-Response Relationship, Drug; Drug Synergism; Enzyme Inhibitors; Fluorouracil; Humans; Intestinal Neoplasms; Irinotecan; Leucovorin; Thymidylate Synthase; Thymine Nucleotides; Topoisomerase I Inhibitors; Tumor Cells, Cultured | 1998 |